Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 267-032-7 | CAS number: 67762-73-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 26 January 2016 to 2 March 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Bicyclo[3.1.1]hept-2-ene, 2,6,6-trimethyl-, phosphosulfurized
- EC Number:
- 267-032-7
- EC Name:
- Bicyclo[3.1.1]hept-2-ene, 2,6,6-trimethyl-, phosphosulfurized
- Cas Number:
- 67762-73-6
- IUPAC Name:
- Bicyclo[3.1.1]hept-2-ene, 2,6,6-trimethyl-, phosphosulfurized
- Test material form:
- other: Liquid
- Details on test material:
- - Name of test material (as cited in study report): EXP1506833
- Substance type: UVCB
- Physical state: amber colored viscous liquid
- Storage condition of test material: room temperature in the dark
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo RMS B.V.
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 15-23g
- Housing: suspended solid floor polypropylene cages furnished with softwood flakes
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 30-70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 hrs dark/ 12 hrs light
Study design: in vivo (LLNA)
- Vehicle:
- methyl ethyl ketone
- Concentration:
- 10 %, 25 % and 50 % v/v in methyl ethyl ketone
- No. of animals per dose:
- 4 animals per dose
- Details on study design:
- Groups of four mice were treated with the test item at concentrations of 50 %, 25 % or 10 % w/w in methyl ethyl ketone. The preliminary screening test suggested that the test item would not produce systemic toxicity or excessive local skin irritation at the highest suitable concentration. The mice were treated by daily application of 25 µL of the appropriate concentration of the test item to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The test item formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette. A further group of four mice received the vehicle alone in the same manner.
Five days following the first topical application of the test item or vehicle (Day 6) all mice were injected via the tail vein with 250 µL of phosphate buffered saline (PBS) containing 3H-methyl thymidine (3HTdR: 80 µCi/mL, specific activity 2.0 Ci/mmoL, ARC UK Ltd) giving a total of 20 µCi to each mouse.
Clinical Observations: All animals were observed twice daily on Days 1, 2 and 3 and on a daily basis on Days 4, 5 and 6. Any signs of toxicity or signs of ill health during the test were recorded.
Body Weights: The body weight of each mouse was recorded on Day 1 (prior to dosing) and Day 6 (prior to termination).
Termination: Five hours following the administration of 3HTdR all mice were killed by carbon dioxide asphyxiation followed by cervical separation. The draining auricular lymph nodes from the four mice were excised and pooled for each experimental group. For each group 1 mL of PBS was added to the pooled lymph nodes.
Preparation of Single Cell Suspension: A single cell suspension of pooled lymph node cells was prepared by gentle mechanical disaggregation through a 200-mesh stainless steel gauze. The lymph node cells were rinsed through the gauze with 4 mL of PBS into a petri dish labeled with the study number and dose concentration. The lymph node cell suspension was transferred to a centrifuge tube. The petri dish was washed with an additional 5 mL of PBS to remove all remaining lymph node cells and these were added to the centrifuge tube. The pooled lymph node cells were pelleted at 1400 rpm (approximately 190 g) for 10 minutes. The pellet was re-suspended in 10 mL of PBS and re-pelleted. To precipitate out the radioactive material, the pellet was re-suspended in 3 mL of 5 % Trichloroacetic acid (TCA).
Determination of 3HTdR Incorporation: After approximately 18 hours incubation at approximately 4 °C, the precipitates were recovered by centrifugation at 2100 rpm (approximately 450 g) for 10 minutes, re-suspended in 1 mL of TCA and transferred to 10 mL of scintillation fluid. 3HTdR incorporation was measured by ß-scintillation counting. The "Poly Q™" vials containing the samples and scintillation fluid were placed in the sample changer of the scintillator and left to stand in darkness for approximately 20 minutes. The purpose of this period of time in darkness was to reduce the risk of luminescence, which has been shown to affect the reliability of the results. After approximately 20 minutes, the vials were shaken vigorously. The number of radioactive disintegrations per minute was then measured using the Beckman LS6500 scintillation system (Beckman Instruments Inc, Fullerton, CA, USA). - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- None
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- EC3
- Value:
- 44
- Remarks on result:
- other: Positive
- Parameter:
- SI
- Value:
- 1.22
- Test group / Remarks:
- 10% v/v
- Remarks on result:
- other: Negative
- Parameter:
- SI
- Value:
- 1.41
- Test group / Remarks:
- 25% v/v
- Remarks on result:
- other: Negative
- Parameter:
- SI
- Value:
- 3.5
- Test group / Remarks:
- 50% v/v
- Remarks on result:
- other: Positive
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Vehicle = 1708.28 dpm (213.54 dpm/Node) 10% w/w = 2091.34 dpm (261.42 dpm/Node) 25% w/w = 2408.25 dpm (301.03 dpm/Node) 50% w/w = 5977.14 dpm (741.14 dpm/Node)
Any other information on results incl. tables
Stimulation Index and results of each treatment
Concentration (%v/v) in methyl ethyl ketone | Stimulation Index | Result |
10 | 1.22 | Negative |
25 | 1.41 | Negative |
50 | 3.50 | Positive |
Measurement of Ear Thickness and Mean Ear Thickness Changes – Preliminary Screening Test
Concentration (% w/w) in methyl ethyl ketone | Animal Number | Ear Thickness Measurement (mm) | |||||
Day 1 | Day 3 | Day 6 | |||||
pre-dose | post dose | ||||||
left | right | left | right | left | right | ||
50 | S-1 | 0.21 | 0.22 | 0.24 | 0.22 | 0.20 | 0.20 |
overall mean (nm) | 0.22 | 0.23 | 0.20 | ||||
overall mean ear thickness change (%) | na | 6.98 | -6.98 |
Disintegrations per minute, disintegrations per minute/node and stimulation index
Concentration (% v/v) in methyl ethyl ketone | dpm | dpm/Node | Stimulation Index | Result |
Vehicle | 1708.28 | 213.54 | na | na |
10 | 2091.34 | 261.42 | 1.22 | Negative |
25 | 2408.25 | 301.03 | 1.41 | Negative |
50 | 5977.14 | 741.14 | 3.50 | Positive |
Individual Clinical Observations and Mortality Data
Concentration (% w/w) in methyl ethyl ketone | Animal Number | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | |||
Pre-Dose | Post-Dose | Pre-Dose | Post-Dose | Pre-Dose | Post-Dose | |||||
Vehicle | 1-1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1-2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
1-3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
1-4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
10 | 2-1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2-2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
2-3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
2-4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
25 | 3-1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3-2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
3-3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
3-4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
50 | 4-1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4-2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
4-3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
4-4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Individual Body Weights and Body Weight Change
Concentration (% w/w) in methyl ethyl ketone | Animal Number | Body Weight (g) | Body Weight Change (g) | |
Day 1 | Day 6 | |||
Vehicle | 1-1 | 16.6 | 17.4 | 0.8 |
1 -2 | 17.7 | 18.4 | 0.7 | |
1 -3 | 17.2 | 17.5 | 0.3 | |
1 -4 | 17.8 | 18.6 | 0.6 | |
10 | 2 -1 | 18.2 | 18.8 | 0.6 |
2 -2 | 19.2 | 19.8 | 0.6 | |
2 -3 | 18.1 | 18.6 | 0.5 | |
2 -4 | 17.7 | 18.1 | 0.4 | |
25 | 3 -1 | 19.6 | 20.3 | 0.7 |
3 -2 | 18.1 | 18.8 | 0.7 | |
3 -3 | 16.4 | 17.3 | 0.9 | |
3 -4 | 18.0 | 18.9 | 0.9 | |
50 | 4 -1 | 20.1 | 20.7 | 0.6 |
4 -2 | 18.3 | 19.2 | 0.9 | |
4 -3 | 20.5 | 20.9 | 0.4 | |
4 -4 | 19.0 | 20.3 | 1.3 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- The Stimulation Index - expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group - provided a positive result for the highest suitable concentration tested. The test substance therefore is classified as sensitising according to the criteria for classification according to Regulation (EC) No.1272/2008 on the Classification, Labelling and Packaging of Substances and Mixtures.
- Executive summary:
The in vivo skin sensitisation of the test substance was determined in accordance with the OECD Guideline for Testing of Chemicals 429. A Local Lymph Node Assay (LLNA) was performed to assess the skin sensitization potential of the registered substance in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear.
Following a preliminary screening test in which no clinical signs of toxicity were noted at a concentration of 50 % w/w, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. Three groups, each of four animals, were treated with 50 µL (25 µL per ear) of the registered substance as a suspension in methyl ethyl ketone at concentrations of 50 %, 25 % or 10 % w/w. A further group of four animals was treated with methyl ethyl ketone alone.
The Stimulation Index - expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group - provided a positive result for the highest concentration tested. The test substance therefore is classed as sensitising according to the criteria for classification according to Regulation (EC) No.1272/2008 on the Classification, Labelling and Packaging of Substances and Mixtures.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.